Guangzhou Boji Medical & Biotechnological Co Ltd (300404):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Guangzhou Boji Medical & Biotechnological Co Ltd (300404) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9371
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangzhou Boji Medical & Biotechnological Co Ltd (BOJI) is a contract research organization. The organization provides services including regulatory affairs, preclinical research, clinical trials I-IV, PMS, clinical trial for medical devices, post marketing studies (PMS), data management and biostatistics, SMO and other services. Its preclinical research services comprise research of chemical API synthesis process, research of drug preparation process, research of stability, testing of microbial limits and method validation, development of therapeutic protein products and others. The organization’s clinical trials I-IV’s services include management of clinical trial plans and conduction of clinical trial phase i-iv, conduction of BA and BE study, handling clinical trial related issues, and conduction of global multi-center clinical trial. BOJI is headquartered in Guangzhou, China.

Guangzhou Boji Medical & Biotechnological Co Ltd (300404) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Guangzhou Boji Medical Forms Joint Venture with Wang Fengtan 10
Guangzhou Boji Medical Plans to Form Joint Venture with Jiangxi-Based Pharma Company 11
Guangzhou Boji Medical and Biotech to Form Joint Venture in China 12
Equity Offering 13
Guangzhou Boji Medical Biotech Prices IPO of Shares for USD34.6 Million 13
Guangzhou Boji Medical & Biotechnological Co Ltd – Key Competitors 15
Guangzhou Boji Medical & Biotechnological Co Ltd – Key Employees 16
Guangzhou Boji Medical & Biotechnological Co Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Boji Medical & Biotechnological Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Guangzhou Boji Medical Forms Joint Venture with Wang Fengtan 10
Guangzhou Boji Medical Plans to Form Joint Venture with Jiangxi-Based Pharma Company 11
Guangzhou Boji Medical and Biotech to Form Joint Venture in China 12
Guangzhou Boji Medical Biotech Prices IPO of Shares for USD34.6 Million 13
Guangzhou Boji Medical & Biotechnological Co Ltd, Key Competitors 15
Guangzhou Boji Medical & Biotechnological Co Ltd, Key Employees 16

List of Figures
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangzhou Boji Medical & Biotechnological Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Guangzhou Boji Medical & Biotechnological Co Ltd (300404):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PostNL NV (PNL):企業の財務・戦略的SWOT分析
    PostNL NV (PNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Daicel Corp (4202)
    Daicel Corp (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Albéa Beauty Holdings S.A.:戦略・SWOT・企業財務分析
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Chorus Clean Energy AG (CU1):電力:M&Aディール及び事業提携情報
    Summary Chorus Clean Energy AG (Chorus Clean) is a renewable energy company that offers solar energy and wind energy development services. The company's services include technical and commercial management, asset sourcing, operational management, due diligence, documentation and reporting, commercia …
  • Fortune Brands Home & SecurityInc:戦略・SWOT・企業財務分析
    Fortune Brands Home & SecurityInc - Strategy, SWOT and Corporate Finance Report Summary Fortune Brands Home & SecurityInc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • HITT Contracting Inc:企業の戦略的SWOT分析
    HITT Contracting Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • California Physicians’ Service:企業の戦略的SWOT分析
    California Physicians' Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • vTv Therapeutics Inc (VTVT):企業の財務・戦略的SWOT分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases includ …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As:企業の戦略・SWOT・財務分析
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • CymaBay Therapeutics Inc (CBAY):製薬・医療:M&Aディール及び事業提携情報
    Summary CymaBay Therapeutics Inc (CymaBay), formerly Metabolex Inc is a clinical-stage biopharmaceutical company that develops therapeutics to treat diabetes, orphan diseases and related metabolic disorders. The company’s pipeline products comprise Arhalofenate, an oral small molecule intended for t …
  • Rehrig Pacific Company:企業の戦略的SWOT分析
    Rehrig Pacific Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Energy Transfer Partners, L.P.:企業の戦略・SWOT・財務情報
    Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AcelRx Pharmaceuticals Inc (ACRX):企業の財務・戦略的SWOT分析
    AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Home Capital Group Inc.:企業の戦略・SWOT・財務分析
    Home Capital Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Home Capital Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Meridian Bioscience Inc (VIVO):医療機器:M&Aディール及び事業提携情報
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for viral, gastrointestinal, respiratory and parasitic infectious disease indications. It also manufactures bulk antigens, an …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務分析
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Olympus Corp (7733):医療機器:M&Aディール及び事業提携情報
    Summary Olympus Corporation (Olympus) provides precision machinery and instruments. It develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, medical endoscopes and t …
  • Kang Stem Biotech Co Ltd (217730):製薬・医療:M&Aディール及び事業提携情報
    Summary Kang Stem Biotech Co Ltd (Kang Stem Biotech) is a biopharmaceutical company that develops stem cell therapeutic products for the treatment of incurable diseases using umbilical cord blood-derived stem cells. The company’s stem cell therapy products include Furestem-AD for treating subacute a …
  • Habib Metropolitan Bank Limited
    Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Habib Metropolitan Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Even Construtora E Incorporadora Sa
    Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report Summary Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆